Aeglea BioTherapeutics, Inc. (AGLE) Social Stream



Aeglea BioTherapeutics, Inc. (AGLE): $12.01

0.97 (+8.79%)

POWR Rating

Component Grades

Momentum

D

Stability

F

Sentiment

Quality

D

Add AGLE to Watchlist
Sign Up

Industry: Biotech

Industry

F

Ranked

#246 of 339

in industry

Featured Post From StockTwits About AGLE

ɢʟᴛᴀ.
$AGLE
** Re-post 1 hour ago **
2021-07-15 16:30 ET

Aeglea BioTherapeutics Announces Publication of 20 Week Data from Phase 1/2 and Open-Label Extension Studies of Pegzilarginase for the Treatment of Arginase 1 Deficiency in the Journal of Inherited Metabolic Disease
https://stonkmoon.com/news/AGLE/2efcc18c0556095eecd4cde1dcb70de7
Stonkmoon, published July 15, 2021

Loading social stream, please wait...


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!